Condition
Behavioral Variant Frontotemporal Dementia (bvFTD)
Total Trials
6
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed3
Enrolling By Invitation1
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07567664Not ApplicableEnrolling By Invitation
Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases
NCT06870838Active Not Recruiting
Neuroinflammation in FTLD
NCT04363684Recruiting
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
NCT03272230Not ApplicableCompleted
Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System
NCT02365922Completed
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
NCT01626378Phase 3CompletedPrimary
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Showing all 6 trials